Investigating Potential Biomarkers in Autism Spectrum Disorder

BackgroundEarly identification and treatment of individuals with autism spectrum disorder (ASD) improves outcomes, but specific evidence needed to individualize treatment recommendations is lacking. Biomarkers that could be routinely measured within the clinical setting could potentially transform c...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Frontiers in Integrative Neuroscience
المؤلفون الرئيسيون: Carolyn Bridgemohan, David M. Cochran, Yamini J. Howe, Katherine Pawlowski, Andrew W. Zimmerman, George M. Anderson, Roula Choueiri, Laura Sices, Karen J. Miller, Monica Ultmann, Jessica Helt, Peter W. Forbes, Laura Farfel, Stephanie J. Brewster, Jean A. Frazier, Ann M. Neumeyer
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Frontiers Media S.A. 2019-08-01
الموضوعات:
autism
ASD
biomarkers
serotonin
melatonin
dysmorphology
الوصول للمادة أونلاين:https://www.frontiersin.org/article/10.3389/fnint.2019.00031/full

الانترنت

https://www.frontiersin.org/article/10.3389/fnint.2019.00031/full

مواد مشابهة